Warning letter
Adventist Health Walla Walla General Hospital: warning letter of Jul 13, 2001
FDA warning letter UCM178802 · Seattle District Office
Key facts
| Reference number | UCM178802 |
|---|---|
| Company | Adventist Health Walla Walla General Hospital |
| Subject | GMP for Blood & Blood Components/General Biological Standards |
| Issue date | Jul 13, 2001 |
| Posted date | Jul 13, 2001 |
| Issuing office | Seattle District Office |
| Product type | Biologics |
| CFR sections cited | 606, 606.160, 610, 606.60(a), 606.65(e), 640.34(b) |
| Country | 3 |
| Inspection city | Walla Walla |
| Inspection ZIP | 99362-4116 |
| Inspection start date | Jun 21, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: